Literature DB >> 28648534

Promising Outcome of Anatomic Correction of Corrected Transposition of the Great Arteries.

Viktor Hraska1, Mathieu Vergnat2, Peter Zartner2, Chris Hart2, Phillip Suchowerskyj2, Benjamin Bierbach2, Ehrenfried Schindler2, Martin Schneider2, Boulos Asfour2.   

Abstract

BACKGROUND: Anatomic correction of corrected transposition of the great arteries with associated lesions, utilizing the morphologic left ventricle as a systemic pumping chamber, is the preferred method in many centers. The purpose of this study was to analyze functional outcome after anatomic correction.
METHODS: Between Jan 1997 and May 2016, 63 patients with corrected transposition of the great arteries and associated lesions underwent anatomic correction. Forty-two patients (67%) underwent palliation before correction, including 14 patients (22%) who required training of systemic ventricle. The double switch procedure was performed in 37 patients; 25 patients underwent the Senning-Rastelli operation, and 1 patient underwent the Senning-Nikaidoh procedure. The median age at correction was 1.6 ± 3.7(SD) years (range, 0.2 to 17.8 years).
RESULTS: The survival and freedom from any event was 95% and 71%, respectively, at 15-year follow-up. The combined freedom from death, failure of systemic ventricle, or heart transplant was 93% at 15-year follow-up regardless of procedure type. Sinus rhythm was present in 49 patients, with 14 patients requiring pacemaker (22%)-8 preoperatively, 4 early postoperatively, and 2 late postoperatively. Neurological development is normal in all patients. Fifty-four percent of the patients are not on medication.
CONCLUSIONS: Anatomic correction of corrected transposition of the great arteries is a safe procedure that provides encouraging survival and functional benefits. Ninety-three percent preservation of morphological left ventricle function in 15 years of follow-up supports the concept of anatomic correction. Longer follow-up is needed to confirm superiority of this approach over other management strategies.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28648534     DOI: 10.1016/j.athoracsur.2017.04.050

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  The paradox of choice in the surgical management of congenitally corrected transposition: what should we do with all of these options supported by little evidence?

Authors:  Catherine Deshaies; Paul Khairy
Journal:  Transl Pediatr       Date:  2018-01

2.  Is one-and-a-half better than two?

Authors:  David J Barron
Journal:  Transl Pediatr       Date:  2018-01

3.  Anatomic Repair of Congenitally Corrected Transposition: Reappraisal of Eligibility Criteria.

Authors:  Viktoria H M Weixler; Peter Kramer; Peter Murin; Olga Romanchenko; Mi-Young Cho; Stanislav Ovroutski; Michael Hübler; Felix Berger; Joachim Photiadis
Journal:  Pediatr Cardiol       Date:  2022-02-11       Impact factor: 1.838

4.  The Epidemiology of Persons Living with Fontan in 2020 and Projections for 2030: Development of an Epidemiology Model Providing Multinational Estimates.

Authors:  Leandra Plappert; Susan Edwards; Assunta Senatore; Angela De Martini
Journal:  Adv Ther       Date:  2021-12-22       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.